Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5773395

O=C(CCc1cnoc1-c1ccc(F)cc1)N1CCN(CC=Cc2ccccc2)CC1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
GAA P10253 1/20 0.48
USP2 O75604 2/20 0.46
TSHR P16473 2/20 0.46
ALDH1A1 P00352 1/20 0.46
KMT2A Q03164 4/20 0.46
MEN1 O00255 3/20 0.46
MAPT P10636 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
KDM4E B2RXH2 1/20 0.45
THRB P10828 1/20 0.42
MAPK1 P28482 3/20 0.42
GPR183 P32249 1/20 0.42
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2C9 P11712 1/20 0.41
THPO P40225 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5773386 1.00 LMNA (0.48) LMNASMN1; SMN2GAAUSP2TSHR
Trifluoroacetic Acid SCHEMBL5776822 0.85 DPP8 (0.50) TSHRALDH1A1KMT2AMEN1MAPT
Trifluoroacetic Acid SCHEMBL5776847 0.84 MDM2 (0.39) TSHRALDH1A1KMT2AMEN1MAPT
Trifluoroacetic Acid SCHEMBL5772610 0.83 GFER (0.53) LMNATSHRKMT2AMEN1MAPT
Trifluoroacetic Acid SCHEMBL5772964 0.83 TSHR (0.45) TSHRKMT2AMEN1KDM4ECYP3A4
Trifluoroacetic Acid SCHEMBL5776834 0.82 HTT (0.46) LMNASMN1; SMN2KMT2AMAPTHTR1A
Trifluoroacetic Acid SCHEMBL5770006 0.81 KDM4E (0.39) LMNASMN1; SMN2GAATSHRALDH1A1
Trifluoroacetic Acid SCHEMBL5777433 0.81 GFER (0.53) LMNAGAATSHRALDH1A1KMT2A
Trifluoroacetic Acid SCHEMBL5775321 0.81 KMT2A (0.53) LMNASMN1; SMN2GAATSHRALDH1A1
Trifluoroacetic Acid SCHEMBL5907110 0.81 DPP8 (0.51) LMNAGAAUSP2TSHRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR LMNA 2770/4885SMN1; SMN2 3383/4885GAA 2207/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 LMNA 2605/4885SMN1; SMN2 2449/4885GAA 1930/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.